WHO ICTRP trial
Cardiac biomarker prediction of anthracycline related cardiotoxicity in breast…
ChiCTR2200055840 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200055840 |
|---|---|
| Public title | Cardiac biomarker prediction of anthracycline related cardiotoxicity in breast cancer subjects: A multicenter clinical trial |
| Scientific title | Cardiac biomarker prediction of anthracycline related cardiotoxicity in breast cancer subjects: A multicenter clinical trial |
| Primary sponsor | the First Affiliated Hospital of Dalian Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | Cardio-oncology |
| Interventions | Patients with breast cancer:None |
| Registration date | Jan 20, 2022 |
| Target size | Patients with breast cancer:526 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: